Alidad Mireskandari, PhD, MBA

Dr. Mireskandari has over 12 years of life sciences industry experience with a focus on molecular diagnostic test development and commercialization, including regulatory and reimbursement expertise. Dr. Mireskandari most recently served as Chief Development Officer of Interpace Biosciences, and prior to that as President & CEO of JS Genetics. From 2000 to 2009, Dr. Mireskandari was a hedge fund manager in charge of Life Sciences trading portfolios of Nomura Securities, BNP Paribas and Raeburn Advisors. Prior to this experience, he was a research fellow at National Institutes of Health’s National Cancer Institute.  Dr. Mireskandari holds his Ph.D. in Genetics from George Washington University and his MBA from the University of Michigan Ross School of Business.

Leave a Reply

Your email address will not be published. Required fields are marked *